Researchers characterized the transcriptional and epigenetic landscape with the isocitrate dehydrogenase (IDH) 2i AG-221, using an IDH2 mutated AML cell line model and AML patient cohorts.
[Leukemia]
Home Newsletters Hematopoiesis News Perturbed Epigenetic Transcriptional Regulation in AML with IDH Mutations Causes Increased Susceptibility...
